0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Friedreich Ataxia - Pipeline Insight, 2019
Published Date: March 2019
|
Report Code: DELV-Pipe-223
Home | Market Reports | Health | Health Conditions
Friedreich Ataxia Pipeline Insight 2019

Friedreich Ataxia - Pipeline Insight, 2019

Code: DELV-Pipe-223
Report
March 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

"Friedreich Ataxia - Pipeline Insight, 2019” report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Friedreich Ataxia development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:
• Clinical
• Non-clinical
• Inactive: Discontinued and/or Dormant

Descriptive coverage of pipeline development activities for Friedreich Ataxia
Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Pipeline Therapeutics assessment of products for Friedreich Ataxia
The report assesses the active Friedreich Ataxia pipeline products by developmental stage, product type, molecule type, and administration route.

Methodology
Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts.
Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

Scope of the report
• The report provides a snapshot of the pipeline development for the Friedreich Ataxia
• The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Friedreich Ataxia
• The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Friedreich Ataxia
• The report also covers the dormant and discontinued pipeline projects related to the Friedreich Ataxia

Reasons to Buy
• Establish comprehensive understanding of the pipeline activity across this Friedreich Ataxia to formulate effective R&D strategies
• Gather information of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine
• Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Friedreich Ataxia therapeutics
• Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress

1. Report Introduction
2. Friedreich Ataxia Overview
3. Pipeline Therapeutics
• An Overview of Pipeline Products for Friedreich Ataxia
4. Comparative Analysis
5. Products in Clinical Stage
5.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
6. Products in Pre-Clinical and Discovery Stage
6.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
7. Therapeutic Assessment
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type
8. Inactive Products
8.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

LIST OF TABLES :

Table 1: Total Products for Friedreich Ataxia
Table 2: Products in Clinical Stage
Table 3: Products in Non-clinical Stage
Table 4: Assessment by Route of Administration
Table 5: Assessment by Stage and Route of Administration
Table 6: Assessment by Molecule Type
Table 7: Assessment by Stage and Molecule Type
Table 8: Inactive Products

LIST OF FIGURES :

Figure 1: Total Products for Friedreich Ataxia
Figure 2: Products in Clinical Stage
Figure 3: Products in Non-clinical Stage
Figure 4: Assessment by Route of Administration
Figure 5: Assessment by Stage and Route of Administration
Figure 6: Assessment by Molecule Type
Figure 7: Assessment by Stage and Molecule Type
Figure 8: Inactive Products

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$1250
This license allows only one user to access the PDF.

Electronic (PDF)
$2500
This license allows all the users of an enterprise residing in one location to access the PDF

Electronic (PDF)
$4000
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Samsung SD

RELATED REPORTS

Global Cardiac Monitoring Products Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Cardiac Monitoring Products Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-10A290
Mon Sep 27 00:00:00 UTC 2021

Add to Cart

Global and United States Radiation Oncology Market Size Status and Forecast 2021 2027
Global and United States Radiation Oncology Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-18B3286
Mon Sep 27 00:00:00 UTC 2021

Add to Cart

Global and China Glucose Meters Market Insights Forecast to 2027
Global and China Glucose Meters Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-13W3412
Mon Sep 27 00:00:00 UTC 2021

Add to Cart

Global Coronary Atherectomy Devices Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Coronary Atherectomy Devices Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

In 2020 the global Coronary Atherectomy Devices market size was US 240 million and it is expected to reach US 375.6 million by the end of 2027 with a CAGR of 6.6 during 20212027.Global Coronary Atherectomy Devices Market Size Manufacturers Supply Chain Sales Channel and Clients 20212027.

120 Pages
Type: Report
Code: QYRE-Auto-12P242
Mon Sep 27 00:00:00 UTC 2021

Add to Cart